［1］Chistiakov DA，Hellemans B，Volckaert F.Microsatellites and their genomic distribution，evolution，function and applications：A review with special reference to fish genetics［J］.Aquaculture，2006，255(1-4)：1-29.
[2]Velho S，Fernandes MS，Leite M，et al.Causes and consequences of microsatellite instability in gastric carcinogenesis［J］.World J Gastroenterol，2014，20(44)：16433-16442.
[3]Richman S.Deficient mismatch repair：Read all about it (review)［J］.Int J Oncol，2015，47(4)：1189-1202.
[4]Ottini L，Falchetti M，Lupi R，et al.Patterns of genomic instability in gastric cancer：Clinical implications and perspectives［J］.Ann Oncol，2006，17(Suppl 7)：vii97-102.
[5]Bae YS，Kim H，Noh SH，et al.Usefulness of immunohistochemistry for microsatellite instability screening in gastric cancer［J］.Gut Liver，2015，9(5)：629-635.
[6]Boland CR，Thibodeau SN，Hamilton SR，et al.A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition：Development of international criteria for the determination of microsatellite instability in colorectal cancer［J］.Cancer Res，1998，58(22)：5248-5257.
[7]Suraweera N，Duval A，Reperant M，et al.Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR［J］.Gastroenterology，2002，123(6)：1804-1811.
[8]Bacani J，Zwingerman R，Di Nicola N，et al.Tumor microsatellite instability in early onset gastric cancer［J］.J Mol Diagn，2005，7(4)：465-477.
[9]Mathiak M，Warneke VS，Behrens HM，et al.Clinicopathologic characteristics of microsatellite instable gastric carcinomas revisited：Urgent need for standardization［J］.Appl Immunohistochem Mol Morphol，2017，25(1)：12-24.
[10]Li B，Liu HY，Guo SH，et al.Microsatellite instability of gastric cancer and precancerous lesions［J］.Int J Clin Exp Med，2015，8(11)：21138-21144.
[11]Marrelli D，Polom K，Pascale V，et al.Strong prognostic value of microsatellite instability in intestinal type non-cardia gastric cancer［J］.Ann Surg Oncol，2016，23(3)：943-950.
[12]Kim JY，Shin NR，Kim A，et al.Microsatellite instability status in gastric cancer：A reappraisal of its clinical significance and relationship with mucin phenotypes［J］.Korean J Pathol，2013，47(1)：28-35.
[13]Polom K，Marrelli D，Roviello G，et al.Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability［J］.J Surg Oncol，2017,115(3):344-350.
[14]Beghelli S，de Manzoni G，Barbi S，et al.Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers［J］.Surgery，2006，139(3)：347-356.
[15]An JY，Kim H，Cheong JH，et al.Microsatellite instability in sporadic gastric cancer：Its prognostic role and guidance for 5-FU based chemotherapy after R0 resection［J］.Int J Cancer，2012，131(2)：505-511.
[16]Zhu L，Li Z，Wang Y，et al.Microsatellite instability and survival in gastric cancer：A systematic review and Meta-analysis［J］.Mol Clin Oncol，2015，3(3)：699-705.
[17]Choi YY，Bae JM，An JY，et al.Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with Meta-analysis［J］.J Surg Oncol，2014，110(2)：129-135.
[18]Giampieri R，Maccaroni E，Mandolesi A，et al.Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy［J］.Gastric Cancer，2017，20(1)：156-163.
[19]Kim KJ，Lee KS，Cho HJ，et al.Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers［J］.Hum Pathol，2014，45(2)：285-293.
[20]Tan WJ，Hamzah JL，Acharyya S，et al.Evaluation of long-term outcomes of microsatellite instability status in an Asian cohort of sporadic colorectal cancers［J］.J Gastrointest Cancer，2017，9454：1-8.
[21]Thomas ML，Hewett PJ，Ruszkiewicz AR，et al.Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer：Microsatellite unstable cases benefit［J］.Asia Pac J Clin Oncol，2015，11(4)：343-351.
[22]Oki E，Kakeji Y，Zhao Y，et al.Chemosensitivity and survival in gastric cancer patients with microsatellite instability［J］.Ann Surg Oncol，2009，16(9)：2510-2515.
[23]Kim SY，Choi YY，An JY，et al.The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer：Results from a large cohort with subgroup analyses［J］.Int J Cancer，2015，137(4)：819-825.
[24]Sun XW，Zhan YQ，Li W，et al.Influence of neoadjuvant chemotherapy on microsatellite instability in gastric carcinoma［J］.Ai Zheng，2006，25(12)：1493-1496.
[25]Sue S，Shibata W，Maeda S.Helicobacter pylori-induced signaling pathways contribute to intestinal metaplasia and gastric carcinogenesis［J］.Biomed Res Int，2015，2015：737621.
[26]Kim JJ，Tao H，Carloni E，et al.Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells［J］.Gastroenterology，2002，123(2)：542-553.
[27]Santos JC，Brianti MT，Almeida VR，et al.Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway［J］.Mol Carcinog，2017，56(4)：1372-1379.
[28]Alvarez MC，Santos JC，Maniezzo N，et al.MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults［J］.World J Gastroenterol，2013，19(20)：3043-3051.
[29]Park DI，Park SH，Kim SH，et al.Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein［J］.Helicobacter，2005，10(3)：179-184.
[30]Watari J，Moriichi K，Tanabe H，et al.Biomarkers predicting development of metachronous gastric cancer after endoscopic resection：An analysis of molecular pathology of Helicobacter pylori eradication［J］.Int J Cancer，2012，130(10)：2349-2358.
[31]Ohara T，Kasanuki J，Ohara H，et al.Analysis of the differences in structural chromosomal aberrations of the gastric mucosa between H.pylori positive and negative gastric cancer patients：Involvement of H.pylori in the onset of gastric cancer and examination of the mechanism in gastric carcinogenesis following H.pylori eradication［J］.Oncol Rep，2006，16(6)：1333-1342.
[32]Kawanaka M，Watari J，Kamiya N，et al.Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment：Analysis of molecular alterations by a randomised controlled trial［J］.Br J Cancer，2016，114(1)：21-29.